Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Enterprise Value: 2020-2025

Historic Enterprise Value for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $7.1 million.

  • Biofrontera's Enterprise Value rose 58.60% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.9 million, marking a year-over-year decrease of 51.47%. This contributed to the annual value of $2.5 million for FY2024, which is 8.92% down from last year.
  • Latest data reveals that Biofrontera reported Enterprise Value of $7.1 million as of Q3 2025, which was up 1,443.64% from -$527,031 recorded in Q2 2025.
  • Biofrontera's Enterprise Value's 5-year high stood at $164.4 million during Q3 2021, with a 5-year trough of -$3.3 million in Q4 2022.
  • Its 3-year average for Enterprise Value is $4.8 million, with a median of $4.5 million in 2024.
  • As far as peak fluctuations go, Biofrontera's Enterprise Value spiked by 14,240.27% in 2023, and later slumped by 428.79% in 2025.
  • Biofrontera's Enterprise Value (Quarterly) stood at $88.7 million in 2021, then plummeted by 103.70% to -$3.3 million in 2022, then soared by 184.75% to $2.8 million in 2023, then decreased by 8.92% to $2.5 million in 2024, then spiked by 58.60% to $7.1 million in 2025.
  • Its Enterprise Value was $7.1 million in Q3 2025, compared to -$527,031 in Q2 2025 and $5.3 million in Q1 2025.